Skip to main content
OpenTrials
Completed

NCT Number: NCT04092075

Safety and Efficacy of the ToothWave -12 Weeks Calculus Study

The objective of the study is to evaluate the safety and efficacy of the home-use device Silk'n toothbrush (ToothWave) for the improvement in dental health through the reduction of plaque, gingivitis, and calculus.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Texas Health Science Center at San Antonio

San Antonio, Texas, 78229-3900, United States

About this study

This is a single blind, prospective study aimed to evaluate the safety and efficacy of the Silk'n toothbrush in reduction of gingivitis, dental plaque and calculus.

The study includes a total of 168 treatment sessions, twice a day, and 5 clinic visits over a period of 12 weeks.

One treatment group (Silk'n toothbrush - ToothWave) and 1 control group (an ADA approved power toothbrush (PTB)) will participate in the study.

For each patient, assessment data will be collected at baseline, 4 weeks, and at 6 weeks. Calculus condition will be measured after 12 weeks in addition to the other timepoints. The average data sets will be calculated for each group.

Treatment is defined as a timed 2 minutes of teeth brushing in a regular manner, twice a day (morning and evening). Brushing will be undertaken using the Silk'n toothbrush and standard fluoride toothpaste. The control group will use a regular PTB and standard fluoride toothpaste.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult subjects aged 18-70, that are in good health.
  • Subject must have:

2.1. Baseline gingivitis (MGI) score of at least 1.80. 2.2. Baseline gingival bleeding (GBI) of ≥1 on at least 20 sites. 2.3. Dental Plaque mean score greater than 0.6 according to the RMNPI (Rustogi Modified Navy Plaque Index).

2.4. Total Calculus deposits greater than 9 according to the Volpe-Manhold Index.

  • Have a minimum of 20 'scorable' teeth (excluding 3rd molars).
  • The subjects should understand the information provided about the investigative nature of the treatment, possible benefits and side effects. Subjects will sign the Informed Consent Form.
  • The subjects should be willing to comply with the study procedure and schedule, including the follow up visits.

Exclusion criteria

  • Current or history of oral cavity cancer or oropharyngeal cancer.
  • Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body.
  • Pregnant or nursing by subject report.
  • Any active condition in the oral cavity at the discretion of the investigator.
  • Any surgery in the oral cavity within 3 months prior to treatment, or before complete healing.
  • Subjects that do not brush regularly.
  • Any condition that might make it unsafe for the subject to participate in this study, at the discretion of the investigator.

Treatment and study plan

RF-utilizing powered toothbrush

Device

RF-utilizing Powered toothbrush

Other names: RF toothbrush

Control placebo with no RF

Device

Placebo control, toothbrush with no RF

Primary outcomes

  1. Calculus

    Time frame: 12 weeks

    A reduction of calculus deposits as compared to control, as evaluated by Volpe-Manhold Index.

Secondary outcomes

  1. Dental plaque

    Time frame: 6 weeks

    A reduction in the level of dental plaque compared to control, according to Rustogi Modification of the Navy.

  2. Gingival inflammation

    Time frame: 6 weeks

    A reduction in the level of gingival inflammation compared to control, according to the Modified Gingival Index (MGI).

Sponsors and collaborators

Lead sponsor

Home Skinovations Ltd.

Industry

Registry information

Official study title

Safety and Efficacy of the Silk'n Toothbrush (ToothWave), Home Use Device for Reduction of Calculus, Gingivitis and Dental Plaque.

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Sep 17, 2019
Registry last updated
Jul 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.